• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小剂量胰高血糖素用于1型糖尿病儿童轻度低血糖的救治:布里斯班经验

Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: the Brisbane experience.

作者信息

Hartley Mary, Thomsett Michael J, Cotterill Andrew M

机构信息

Department of Endocrinology and Diabetes, Mater Children's Hospital, Brisbane, Queensland, Australia.

出版信息

J Paediatr Child Health. 2006 Mar;42(3):108-11. doi: 10.1111/j.1440-1754.2006.00807.x.

DOI:10.1111/j.1440-1754.2006.00807.x
PMID:16509909
Abstract

OBJECTIVES

To evaluate the use of small doses of glucagon using an insulin syringe in mild or impending hypoglycaemia in children with type 1 diabetes.

METHODS

Data were collected from patients attending the Paediatric Diabetes Clinic at the Queensland Diabetes Centre at the Mater Hospital, Brisbane in 2002-2004 following the institution of a new protocol for home management of mild or impending hypoglycaemia associated with inability or refusal to take oral carbohydrate. The protocol recommended the use of subcutaneous injections of glucagon using insulin syringes at a dose of two 'units' (20 microg) in children 2 years of age or younger, and for older children one unit per year of age up to a maximum of 15 units (150 microg), with an additional doubled dose given if the blood glucose had not increased in 20 min.

RESULTS

Over a 2-year period, 25 children were treated with mini-dose glucagon on a total of 38 occasions. Additional doses were required for recurring hypoglycaemia on 20 (53%) occasions. The child could be managed at home on 32 (84%) of these 38 occasions, with only 6 (16%) children needing hospital treatment.

CONCLUSIONS

Our study confirmed that small doses of glucagon given subcutaneously with an insulin syringe is a simple, practical and effective home treatment of mild or impending hypoglycaemia due to gastroenteritis or food refusal in children with type 1 diabetes.

摘要

目的

评估使用胰岛素注射器注射小剂量胰高血糖素治疗1型糖尿病儿童轻度或即将发生的低血糖症的效果。

方法

收集2002年至2004年在布里斯班马特医院昆士兰糖尿病中心儿科糖尿病门诊就诊的患者数据,这些患者遵循了一项新的家庭管理方案,该方案用于治疗与无法或拒绝口服碳水化合物相关的轻度或即将发生的低血糖症。该方案建议,2岁及以下儿童皮下注射胰高血糖素时使用胰岛素注射器,剂量为两个“单位”(20微克),年龄较大的儿童每岁注射一个单位,最大剂量为15个单位(150微克),如果20分钟后血糖没有升高,则额外加倍注射。

结果

在两年时间里,共有25名儿童接受了小剂量胰高血糖素治疗,总共治疗了38次。20次(53%)复发性低血糖症需要额外注射。这38次治疗中有32次(84%)患儿可在家中处理,只有6名(16%)儿童需要住院治疗。

结论

我们的研究证实,使用胰岛素注射器皮下注射小剂量胰高血糖素是治疗1型糖尿病儿童因肠胃炎或拒食导致的轻度或即将发生的低血糖症的一种简单、实用且有效的家庭治疗方法。

相似文献

1
Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: the Brisbane experience.小剂量胰高血糖素用于1型糖尿病儿童轻度低血糖的救治:布里斯班经验
J Paediatr Child Health. 2006 Mar;42(3):108-11. doi: 10.1111/j.1440-1754.2006.00807.x.
2
Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.小剂量胰高血糖素用于1型糖尿病儿童低血糖的抢救
Diabetes Care. 2001 Apr;24(4):643-5. doi: 10.2337/diacare.24.4.643.
3
Mini-doses of glucagon to prevent hypoglycemia in children with type 1 diabetes refusing food: a case series.小剂量胰高血糖素预防拒绝进食的 1 型糖尿病儿童发生低血糖:病例系列研究。
Acta Diabetol. 2020 Mar;57(3):359-365. doi: 10.1007/s00592-019-01443-1. Epub 2019 Oct 31.
4
Prehospital treatment of severe hypoglycaemia: a comparison of intramuscular glucagon and intravenous glucose.严重低血糖的院前治疗:肌肉注射胰高血糖素与静脉注射葡萄糖的比较
Prehosp Disaster Med. 1998 Apr-Dec;13(2-4):44-50.
5
Hypoglycaemia in insulin dependent diabetic patients attending an outpatients' clinic.在门诊就诊的胰岛素依赖型糖尿病患者中的低血糖情况。
N Z Med J. 1990 Jul 25;103(894):339-41.
6
Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.1 型糖尿病患者轻度低血糖治疗中胰高血糖素和胰岛素最佳微量剂量之间的关系——一项模拟研究。
Basic Clin Pharmacol Toxicol. 2018 Mar;122(3):322-330. doi: 10.1111/bcpt.12907. Epub 2017 Oct 11.
7
Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.使用连续血糖监测评估1型糖尿病患者的夜间低血糖:发生率、持续时间及相关因素。
Diabet Med. 2007 May;24(5):527-32. doi: 10.1111/j.1464-5491.2007.02107.x. Epub 2007 Mar 22.
8
Hypoglycaemic episodes in children with insulin dependent diabetes mellitus--can the frequency or severity be reduced?胰岛素依赖型糖尿病患儿的低血糖发作——发作频率或严重程度能降低吗?
Ir Med J. 2001 Feb;94(2):38, 40.
9
Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.德国和奥地利26687例1型糖尿病儿童及青少年的餐时胰岛素替代治疗方案及预测因素
Diabet Med. 2007 Dec;24(12):1478-81. doi: 10.1111/j.1464-5491.2007.02273.x. Epub 2007 Oct 29.
10
Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.使用胰高血糖素对重度持续性先天性高胰岛素血症进行长期非手术治疗。
Horm Res. 2008;70(1):59-64. doi: 10.1159/000129680. Epub 2008 May 21.

引用本文的文献

1
Mini-Dose Glucagon for Mild and Moderate Hypoglycemia in Type 1 Diabetes.小剂量胰高血糖素用于1型糖尿病的轻中度低血糖症
Med Res Arch. 2024 Oct 29;12(10). doi: 10.18103/mra.v12i10.5866.
2
Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model.静脉、腹腔和皮下给予猪模型后胰高血糖素的药代动力学。
Basic Clin Pharmacol Toxicol. 2022 Jun;130(6):623-631. doi: 10.1111/bcpt.13731. Epub 2022 Apr 21.
3
Pharmacokinetics of Intraperitoneally Delivered Glucagon in Pigs: A Hypothesis of First Pass Metabolism.
腹腔内给予胰高血糖素在猪体内的药代动力学:首过代谢假说。
Eur J Drug Metab Pharmacokinet. 2021 Jul;46(4):505-511. doi: 10.1007/s13318-021-00692-2. Epub 2021 Jun 7.
4
Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels.麻醉猪的腹腔内和皮下给予胰高血糖素:对循环胰高血糖素和血糖水平的影响。
Sci Rep. 2020 Aug 13;10(1):13735. doi: 10.1038/s41598-020-70813-5.
5
Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial.大鼠腹腔内、皮下和静脉注射胰高血糖素及其随后的血糖反应:一项随机对照交叉试验。
BMJ Open Diabetes Res Care. 2018 Nov 9;6(1):e000560. doi: 10.1136/bmjdrc-2018-000560. eCollection 2018.
6
Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.影响1型糖尿病自动闭环系统中胰高血糖素给药成功率的因素。
J Diabetes Complications. 2015 Jan-Feb;29(1):93-8. doi: 10.1016/j.jdiacomp.2014.09.001. Epub 2014 Sep 16.
7
Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.降低糖尿病患者低血糖的发病率:小剂量胰高血糖素综述
J Diabetes Sci Technol. 2015 Jan;9(1):44-51. doi: 10.1177/1932296814547518. Epub 2014 Aug 26.
8
Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.在不同胰岛素水平下对皮下注射小剂量胰高血糖素的血糖反应进行定量分析。
Diabetes Care. 2014 Nov;37(11):3054-60. doi: 10.2337/dc14-0803. Epub 2014 Aug 19.
9
Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes.闭环系统中胰高血糖素的新用途:预防 1 型糖尿病低血糖。
Diabetes Care. 2010 Jun;33(6):1282-7. doi: 10.2337/dc09-2254. Epub 2010 Mar 23.